Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: The DETECT study

Annals of the Rheumatic Diseases

Volumn 73, Issue 7, 2014, Pages 1340-1349

  Coghlan, J Gerry ^a   Denton, Christopher P ^a   Grünig, Ekkehard ^b   Bonderman, Diana ^c   Distler, Oliver ^d   Khanna, Dinesh ^e   Müller Ladner, Ulf ^f   Pope, Janet E ^g   Vonk, Madelon C ^h   Doelberg, Martin ⁱ   Chadha Boreham, Harbajan ⁱ   Heinzl, Harald ^c   Rosenberg, Daniel M ⁱ   McLaughlin, Vallerie V ^e   Seibold, James R ^j  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f JUSTUS LIEBIG UNIVERSITY   (Germany)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ ACTELION PHARMACEUTICALS LTD   (Switzerland)

^j Scleroderma Research Consultants LLC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EVIDENCE BASED PRACTICE; FEMALE; HEART CATHETERIZATION; HEMATOMA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT IDENTIFICATION; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS;

ARTERIAL HYPERTENSION; EPIDEMIOLOGY; SYSTEMIC SCLEROSIS;

ADULT; AGED; ALGORITHMS; BREATH TESTS; CARDIAC CATHETERIZATION; CROSS-SECTIONAL STUDIES; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOMOGRAMS; PULMONARY DIFFUSING CAPACITY; PULMONARY WEDGE PRESSURE; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84902249499     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203301     Document Type: Article

References (34)

1. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
2. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009;119:2250-94.
3. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972- 2002. Ann Rheum Dis 2007;66:940-4. (Pubitemid 46999798)
4. Tyndall AJ, Bannet B, Vonk M, et al. Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trial and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809-15.
5. Hachulla E, Carpentier P, Gressin V, et al. Risk factors for death and the 3-year survival of patients with systemic sclerosis: The French ItinérAIR-Sclérodermie study. Rheumatology (Oxford) 2009;48:304-8.
6. Condliffe R, Kiely DG, Peacock AJ, et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009;179:151-7.
7. Launay D, Sitbon O, Hachulla E, et al. Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era. Ann Rheum Dis 2013;72:1940-6.
8. Humbert M, Yaici A, de Groote P, et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum 2011;63:3522-30.
9. Galiè N, Rubin LJ, Hoeper M, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): A double-blind randomized controlled trial. Lancet 2008;371:2093-100. (Pubitemid 351902178)
10. Badesch DB, Champion HC, Gomez Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54(Suppl 1):55-66.
11. Williams MH, Handler CE, Akram R, et al. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 2006;27:1485-94. (Pubitemid 43998084)
12. Steen V, Medsger TA Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003; 48:516-22. (Pubitemid 36278021)
13. Schreiber BE, Valerio CJ, Keir GJ, et al. Improving the detection of pulmonary hypertension in systemic sclerosis using pulmonary function tests. Arthritis Rheum 2011;63:3531-9.
14. Allanore Y, Borderie D, Avouac J, et al. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum 2008;58:284-91.
15. Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009;179:615-21.
16. Parent F, Bachir D, Inamo J, et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med 2011;365:44-53.
17. Wilson JMG, Jungner G. Principles and practice of screening for disease. Public Health Paper, Number 34. Geneva: WHO, 1968.
18. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23: 581-90.
19. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54(Suppl 1):43-54.
20. Harrell FE Jr, Margolis PA, Gove S, et al. Development of a clinical prediction model for an ordinal outcome: The World Health Organization Multicentre Study of Clinical Signs and Etiological agents of Pneumonia, Sepsis and Meningitis in Young Infants. WHO/ARI Young Infant Multicentre Study Group. Stat Med 1998;17:909-44. (Pubitemid 28185168)
21. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study. Arthritis Rheum 2005;52:3792-800. (Pubitemid 41798217)
22. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach. Ann Rheum Dis 2003;62:1088-93. (Pubitemid 37323574)
23. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010;137:376-87.
24. Phung S, Strange G, Chung LP, et al. Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis. Intern Med J 2009;39:682-91.
25. Nihtyanova SI, Tang EC, Coghlan JG, et al. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: A retrospective cohort study. QJM 2010;103:109-15.
26. Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006;48:2546-52. (Pubitemid 44881214)
27. Johnson SR, Fransen J, Khanna D, et al. Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res (Hoboken) 2012;64:358-67.
28. Thenappan T, Shah SJ, Rich S, et al. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 2007;30:1103-10. (Pubitemid 351194756)
29. Cavagna L, Caporali R, Klersy C, et al. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis. J Rheumatol 2010;37:2064-70.
30. Bossone E, Paciocco G, Iarussi D, et al. The prognostic role of the ECG in primary pulmonary hypertension. Chest 2002;121:513-18. (Pubitemid 34132992)
31. Jiang X, Han ZY, Wang Y, et al. Hemodynamic variables and clinical features correlated with serum uric acid in patients with pulmonary arterial hypertension. Chin Med J (Engl) 2008;121:2497-503.
32. Njaman W, Iesaki T, Iwama Y, et al. Serum uric acid as a prognostic predictor in pulmonary arterial hypertension with connective tissue disease. Int Heart J 2007;48:523-32. (Pubitemid 47455802)
33. Avouac J, Huscher D, Furst DE, et al. Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: A Delphi consensus study with cluster analysis. Ann Rheum Dis 2013. Published Online First: 24 Jan 2013. doi:10.1136/annrheumdis-2012- 202567.
34. Valerio CJ, Schreiber BE, Handler CE, et al. Borderline mean pulmonary artery pressure in systemic sclerosis patients: Trans-pulmonary gradient predicts risk of developing pulmonary hypertension. Arthritis Rheum 2012;65:1074-84.